Sellas Life Sciences Shares Fall 12% to $8.55, Hit One-Month Low
Sellas Life Sciences shares fell 12% to $8.55 on Monday, their lowest level in more than a month. Disclosures showed several investment firms increased their third-quarter holdings by as much as 422%, ahead of cancer data.
Sellas Life Sciences (SLS) shares hit their lowest level in more than a month on Monday, with retail bulls buying the dip ahead of cancer data as fresh disclosures showed several investment firms had increased their third-quarter holdings by as much as 422%.SLS shares sank 12% to $8.55 on Monday, t…